Progress in application of Linezolid on treatment of pediatric multi-drug resistant tuberculosis
10.3760/cma.j.cn101070-20200217-00172
- VernacularTitle:利奈唑胺治疗儿童耐多药结核病的应用进展
- Author:
Zeming WANG
1
;
Adong SHEN
Author Information
1. 国家儿童医学中心，首都医科大学附属北京儿童医院，北京市儿科研究所，儿科学国家重点学科，国家呼吸系统疾病临床医学研究中心，儿科重大疾病研究教育部重点实验室，儿童呼吸道感染性疾病研究北京市重点实验室，北京 100045
- From:
Chinese Journal of Applied Clinical Pediatrics
2020;35(10):758-761
- CountryChina
- Language:Chinese
-
Abstract:
Multi-drug resistant tuberculosis remains a serious infection disease endangering children health.Linezolid, as an effective and safe anti-tuberculous drug has achieved good results in the treatment of adults with multi-drug resistant tuberculosis.Recently, some advances have been made associated with Linezolid on treatment of multi-drug-resistant tuberculosis in children.Therefore, in this article, theses progresses were reviewed and the information associated with current status and problems to be solved of Linezolid on the treatment of pediatric multi-drug resistant tuberculosis was introduced to promote its rational application based on published guidelines and researches.
